You Just Found Out You Have Crohn's Disease—Here Are 6 Things Gastroenterologists Recommend You Do First
If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, ...
GlobalData on MSN3d
EMA CHMP recommends Lilly’s Crohn’s therapy for EU approval
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Omvoh ...
Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's
Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...
Teva, Sanofi say bowel disease drug met primary targets
Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...
Medscape6h
FDA Approves Seventh Ustekinumab Biosimilar, Steqeyma
Ustekinumab-stba, manufactured by Celltrion, is expected to be marketed in the United States in February 2025.
South Jersey clinic using intestinal ultrasound as an alternative for people with inflammatory bowel disease
A device used in South Jersey is a game-changer for people with inflammatory bowel disease as an alternative to invasive ...
Armed robbery in Revesby20h
Key Fibrosis Driver in Crohn's Disease Found
Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...
Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease
Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products ...
FierceBiotech1d
Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in midstage trial
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...
Researchers identify key driver of fibrosis in Crohn's disease
Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...
emjreviews.com2d
Lilly gains EU backing for drug to treat Crohn’s disease
The drug has received a nod from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
Pharmabiz7h
Sanofi & Teva Pharma’s RELIEVE UCCD phase 2b study of duvakitug in ulcerative colitis and Crohn’s disease meets primary endpoints
Sanofi & Teva Pharma’s RELIEVE UCCD phase 2b study of duvakitug in ulcerative colitis and Crohn’s disease meets primary endpoints: Paris Thursday, December 19, 2024, 11:00 Hrs ...